The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
Medicine is going digital and regulators are under pressure to keep pace.
The U.S. Food and Drug Administration announced a few months ago that it will create a new unit dedicated to digital health, which will include team of engineers. And on Thursday, the FDA's recently-appointed commissioner Scott Gottlieb went a step further, outlining in a blog post more steps the agency is going to take.
Gottlieb said he's putting together a "digital health innovation plan" that will lay out how devices will be regulated so that developers have clarity on the rules and don't have to seek out the FDA's position on a "case-by-case basis."
Many in the health technology industry are optimistic about the steps being taken.
"Holy smokes," said Bradley Merrill Thompson, a lawyer with the firm Epstein Becker Green, who specializes in digital health and FDA, in an email to CNBC. "I feel like I've died and gone to heaven."
Thompson said that industry groups have been calling for years for the FDA to define how it plans to regulate a category of software called clinical decision support. This broadly refers to tools to help doctors with diagnoses and treatment decisions.
In addition to health IT start-ups, many of the largest technology companies are entering this area with machine learning applications to detect signs of disease from mounds of medical data and images. IBM has made a huge bet on its Watson technology for hospitals, while Alphabet could bring its DeepMind technology to the U.S.
The FDA first announced plans to publish a guidance document in 2011. The 21st Century Cures Act said that software, if intended to help maintain a healthy lifestyle, is generally outside the scope of regulation. Gottlieb promised that the FDA will provide more specific guidelines.
Gottlieb also said the FDA is looking at supporting developers of lower risk digital health products in order to "reduce the time and cost of market entry."
If the agency gets it right, start-ups will really benefit, said Thompson.
"We have been waiting for this for a long, long time," he said.
Watch: FDA to publish list of drugs with no generic competitor